Vascular-type Ehlers-Danlos syndrome caused by a hitherto unknown genetic mutation: A case report

Journal of Medical Case Reports

Volumn 7, Issue , 2013, Pages

  Kashizaki, Fumihiro ^a   Hatamochi, Atsushi ^b   Kamiya, Kazunori ^a   Yoshizu, Akira ^a   Okamoto, Hiroaki ^a  

^a YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; COLLAGEN TYPE 3; COLLAGEN TYPE 3 A1; CREATINE KINASE; D DIMER; FIBRINOGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; LACTATE DEHYDROGENASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANEURYSM; ARTERIAL OXYGEN SATURATION; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD OXYGEN TENSION; CASE REPORT; CELIAC ARTERY; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; COUGHING; CREATINE KINASE BLOOD LEVEL; DISSECTING ANEURYSM; ECCHYMOSIS; EHLERS DANLOS SYNDROME; ERYTHROCYTE SEDIMENTATION RATE; EXON; FEMALE; FIBRINOGEN BLOOD LEVEL; GENETIC ANALYSIS; HEMATOTHORAX; HETEROZYGOTE DETECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; ILIAC ARTERY; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LAPAROTOMY; MESENTERIC ARTERY; MISSENSE MUTATION; PARTIAL THROMBOPLASTIN TIME; PHARYNX DISCOMFORT; PLEURA EFFUSION; PLEURISY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RENAL ARTERY; SKIN BRUISING; SKIN FRAGILITY; SKIN ULCER; SPLEEN ARTERY; THORACOSCOPY; THORAX PAIN; THORAX RADIOGRAPHY; UTERUS BLEEDING; VARICOSIS; VASCULAR TYPE EHLERS DANLOS SYNDROME;

EID: 84873043254     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-7-35     Document Type: Article

References (15)

1. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). P Beighton, A De Paepe, B Steinmann, P Tsipouras, RJ Wenstrup, Am J Med Genet 1998 77 31 37 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O 9557891
2. Ehlers-Danlos syndrome, vascular type. MG Pepin, PH Byers, GeneReviews at GeneTests: Medical Genetics Information Resource (database online) Seattle: University of Washington 1993-2011 Available from http://www.ncbi.nlm.nih.gov/ books/NBK1494
3. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan. A Watanabe, T Kosho, T Wada, N Sakai, M Fujimoto, Y Fukushima, T Shimada, Circ J 2007 71 261 265 10.1253/circj.71.261 17251678
4. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. M Pepin, U Schwarze, A Superti-Furga, PH Byers, N Engl J Med 2000 342 673 680 10.1056/NEJM200003093421001 10706896
5. Vascular type of Ehlers-Danlos syndrome. A Watanabe, T Shimada, J Nihon Med Sch 2008 75 254 261 10.1272/jnms.75.254
6. Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene. R Sadakata, A Hatamochi, K Kodama, A Kaga, T Yamaguchi, T Soma, Y Usui, M Nagata, A Ohtake, K Hagiwara, M Kanazawa, Intern Med 2010 49 1797 1800 10.2169/internalmedicine.49.3435 20720362
7. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen. P Narcisi, AJ Richards, SD Ferguson, FM Pope, Hum Mol Genet 1994 3 1617 1620 10.1093/hmg/3.9.1617 7833919
8. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. GS Oderich, JM Panneton, TC Bower, NM Lindor, KJ Cherry, AA Noel, M Kalra, T Sullivan, P Gloviczki, J Vasc Surg 2005 42 98 106 10.1016/j.jvs.2005.03.053 16012458
9. Nationwide survey of Ehlers-Danlos syndrome, vascular type: a preliminary study supported by research on intractable disease of ministry of health, welfare, and labor. T Kosho, A Watanabe, H Morisaki, Y Fukushima, A Hatamochi, Jap J Genet Counsel 2010 31 157 161
10. Pleuropulmonary pathology of vascular Ehlers-Danlos syndrome: spontaneous laceration, haematoma and fibrous nodules. Y Kawabata, A Watanabe, S Yamaguchi, M Aoshima, A Shiraki, A Hatamochi, T Kawamura, T Uchiyama, A Watanabe, Y Fukuda, Histopathology 2010 56 944 950 10.1111/j.1365-2559.2010.03574.x 20500229
11. Respiratory complications of Ehlers-Danlos syndrome type IV. SB Dowton, S Pincott, L Demmer, Clin Genet 1996 50 510 514 9147885
12. Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene. A Watanabe, Y Kawabata, O Okada, N Tanabe, H Kimura, A Hatamochi, H Shinkai, N Sakai, T Shimada, K Hiroshima, T Kuriyama, Eur Respir J 2002 19 195 198 10.1183/09031936.02.00219202 11843319
13. Ehlers-Danlos syndrome with recurrent spontaneous pneumothoraces and cavitary lesion on chest X-ray as the initial complications. T Ishiguro, N Takayanagi, Y Kawabata, H Matsushima, Y Yoshii, K Harasawa, S Yamaguchi, K Yoneda, Y Miyahara, N Kagiyama, D Tokunaga, F Aoki, H Saito, K Kurashima, M Ubukata, T Yanagisawa, Y Sugita, H Okita, A Hatamochi, Intern Med 2009 48 717 722 10.2169/internalmedicine.48.1818 19420820
14. Ehlers-Danlos syndrome type IV. DP Germain, Orpanet J Rare Dis 2007 2 32 10.1186/1750-1172-2-32
15. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. KT Ong, J Perdu, J De Backer, E Bozec, P Collignon, J Emmerich, AL Fauret, JN Fiessinger, DP Germain, G Georgesco, JS Hulot, A De Paepe, H Plauchu, X Jeunemaitre, S Laurent, P Boutouyrie, Lancet 2010 376 1476 1484 10.1016/S0140-6736(10)60960-9 20825986